Skip to main content
U.S. Department of Energy
Office of Scientific and Technical Information

Effects of indomethacin on long-wave ultraviolet-induced delayed erythema

Journal Article · · J. Invest. Dermatol.; (United States)
Indomethacin, a known inhibitor of prostaglandin synthesis, administered topically as a 2.5% solution, intradermally in 10 mug doses, and orally in a dose of 150 mg/day for 2 days did not diminish the delayed erythema produced by long-wave ultraviolet light (320 to 400 nm). The delayed phototoxic erythema produced by 8-methoxypsoralen and subsequent exposure to the long-wave ultraviolet light was similarly unaffected. By comparison, topical and intradermal indomethacin treatment produced sustained decrease in the erythemal response to ultraviolet radiation in the UVB ranges (290 to 320 nm).
Research Organization:
Harvard Medical School, Boston
OSTI ID:
7291087
Journal Information:
J. Invest. Dermatol.; (United States), Journal Name: J. Invest. Dermatol.; (United States) Vol. 68:3; ISSN JIDEA
Country of Publication:
United States
Language:
English